Venus Medtech (Hangzhou) Inc. (02500) announced that, as of November 30, 2025, its total authorised/registered share capital remained at RMB 441,011,443, composed of 441,010,235 H shares and 1,208 unlisted foreign shares. The company reported no increase or decrease in its issued shares or treasury shares for the period. Accordingly, the total number of issued shares stood at 441,010,235 H shares and 1,208 unlisted foreign shares.

The monthly return also noted 44,101,023 potential shares that may be issued under the existing share option scheme. In addition, a total of 3,114,000 H shares repurchased in December 2021 were disclosed as not yet cancelled as of November 30, 2025. No new funds were raised from option exercises, and no changes occurred in treasury shares during the reporting month.